Migraine Canada | CGRP Monoclonal Antibodies: cost, access coverage
Teva's CGRP-Inhibitor Reduced Monthly Migraine Days in Late-Stage Trial | BioSpace
Robust data and flexible approach put Teva in pole position with anti-CGRP drug in UK
Teva bows out of chronic cluster headache as CGRP drug fizzles in phase 3 | FierceBiotech
Anti-CGRP (Calcitonin Gene-Related Peptide) biologics: a new era for migraine prevention | Neurologybytes
Teva's migraine injection approved in Europe - PMLiVE
Ajovy, Teva's migraine drug, recommended by UK's NICE.
The story with Teva, who has one of the most promising CGRP-based drugs (fremanezumab) (it will likely be delayed until 2019) : r/cgrpMigraine
Teva's AJOVY Approved for Migraine Prevention
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Sverige
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans - ScienceDirect
CGRP: Paving the Path to Migraine and Its Treatment
Fremanezumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Teva's CGRP-Inhibitor Reduced Monthly Migraine Days in Late-Stage Trial | BioSpace
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults
CGRP-targeted antibodies in difficult-to-treat migraine | Nature Reviews Neurology
An Overview of New Biologics for Migraine Prophylaxis
Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions - The Lancet Neurology
Migraine therapies targeting the CGRP pathway: intellectual property landscape | Nature Reviews Drug Discovery
The UK-Israeli Small-Molecule Offensive Against Migraines
NICE's thumbs-up on Lilly's migraine med Emgality leaves rivals from Novartis and Teva in the dust | FiercePharma
Teva's migraine prophylaxis drug now approved in Europe
Frontiers | Protective Role of α-Calcitonin Gene-Related Peptide in Cardiovascular Diseases | Physiology
Teva, after locking up new Ajovy patents, sues Eli Lilly again in heated migraine drug fight | FiercePharma
CGRP antagonists – the headache drugs | LGC Standards
